LOS ANGELES, May 25, 2023 /PRNewswire/ — Aadi Bioscience, Inc. AADI, a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced poster presentations at the 2023 ASCO Annual Meeting taking place June 2-6, 2023, in Chicago, IL. The…Read More
Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology ASCO Annual Meeting Aadi Bioscience NASDAQAADI
